{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:59:32Z","timestamp":1780455572256,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"UK National Institute for Health Research","doi-asserted-by":"crossref","award":["AI054544"],"award-info":[{"award-number":["AI054544"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"UK National Institute for Health Research","doi-asserted-by":"crossref","award":["AI084048"],"award-info":[{"award-number":["AI084048"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"UK National Institute for Health Research","doi-asserted-by":"crossref","award":["AI32725"],"award-info":[{"award-number":["AI32725"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases, NIH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jim.2013.02.007","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T02:03:43Z","timestamp":1361844223000},"page":"39-49","source":"Crossref","is-referenced-by-count":19,"title":["Development of a large scale human complement source for use in bacterial immunoassays"],"prefix":"10.1016","volume":"391","author":[{"given":"Charlotte","family":"Brookes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Kuisma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2013.02.007_bb0005","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/CVI.00081-07","article-title":"Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway","volume":"14","author":"Aase","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(95)00136-O","article-title":"The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains","volume":"14","author":"Ala'Aldeen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2013.02.007_bb0015","first-page":"71","article-title":"Interaction between the coagulation and complement system","volume":"632","author":"Amara","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jim.2013.02.007_bb0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/14760584.3.1.77","article-title":"Serologic correlates of protection for evaluating the response to meningococcal vaccines","volume":"3","author":"Balmer","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jim.2013.02.007_bb0030","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination","volume":"186","author":"Beernink","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.133.2.969","article-title":"Purification and some properties of streptococcal protein G, a novel IgG-binding reagent","volume":"133","author":"Bjorck","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-3083.1984.tb00979.x","article-title":"On the interaction between beta 2-microglobulin and group A streptococci","volume":"20","author":"Bjorck","year":"1984","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0050","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.4049\/jimmunol.157.12.5422","article-title":"Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H","volume":"157","author":"Blackmore","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0045","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.4049\/jimmunol.160.7.3342","article-title":"Identification of the second heparin-binding domain in human complement factor H","volume":"160","author":"Blackmore","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.jim.2013.02.007_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jim.2013.02.007_bb0080","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.02.007_bb0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CVI.00452-06","article-title":"Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay","volume":"14","author":"Findlow","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00068-09","article-title":"Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A\/C polysaccharide vaccine in adults","volume":"16","author":"Findlow","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vaccine.2011.10.068","article-title":"Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source","volume":"30","author":"Gill","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2013.02.007_bb0090","doi-asserted-by":"crossref","first-page":"e34272","DOI":"10.1371\/journal.pone.0034272","article-title":"Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity","volume":"7","author":"Giuntini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2013.02.007_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/IAI.05956-11","article-title":"Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein","volume":"80","author":"Giuntini","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.02.007_bb0100","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2013.02.007_bb0105","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2013.02.007_bb0110","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2005.01.053","article-title":"Experimental disease models for the assessment of meningococcal vaccines","volume":"23","author":"Gorringe","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2013.02.007_bb0115","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/CVI.00118-09","article-title":"Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles","volume":"16","author":"Gorringe","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.02.007_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4161\/hv.8376","article-title":"A fluorescence-based opsonophagocytosis assay to measure the functional activity of antibody to group B Streptococcus","volume":"5","author":"Guttormsen","year":"2009","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.jim.2013.02.007_bb0130","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/IAI.01044-09","article-title":"Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies","volume":"78","author":"Hellerud","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.02.007_bb0135","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children","volume":"25","author":"Henckaerts","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2013.02.007_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/biol.2000.0253","article-title":"Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines","volume":"28","author":"Jodar","year":"2000","journal-title":"Biologicals"},{"issue":"Suppl. 2","key":"10.1016\/j.jim.2013.02.007_bb0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","article-title":"Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy","volume":"164","author":"Kaveri","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.jim.2013.02.007_bb0155","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.molimm.2010.05.011","article-title":"New insights into the molecular mechanisms of classical complement activation","volume":"47","author":"Kojouharova","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0160","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.122.5.2103","article-title":"C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay","volume":"122","author":"Kolb","year":"1979","journal-title":"J. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.jim.2013.02.007_bb0165","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1016\/j.vaccine.2007.04.050","article-title":"Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"25","author":"Kshirsagar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2013.02.007_bb0170","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/0140-6736(92)92561-S","article-title":"Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release","volume":"340","author":"Lehner","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2013.02.007_bb0180","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.ppat.1001027","article-title":"The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement","volume":"6","author":"Lewis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jim.2013.02.007_bb0175","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.4049\/jimmunol.1103748","article-title":"The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci","volume":"188","author":"Lewis","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0185","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.vaccine.2011.12.066","article-title":"Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidis","volume":"30","author":"Martino","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2013.02.007_bb0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0195","first-page":"1869","article-title":"Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation","volume":"100","author":"Mollnes","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.02.007_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.imlet.2004.11.010","article-title":"Complement: central to innate immunity and bridging to adaptive responses","volume":"97","author":"Morgan","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jim.2013.02.007_bb0205","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/CVI.00036-08","article-title":"Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B","volume":"15","author":"Plested","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0210","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.1003623","article-title":"Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip\/H.8 and Laz lipoproteins","volume":"186","author":"Ray","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/127.1.56","article-title":"Bactericidal antibody after colonization with Neisseria meningitidis","volume":"127","author":"Reller","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2013.02.007_bb0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0225","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0161-5890(93)90079-Q","article-title":"Identification of multiple sites of interaction between heparin and the complement system","volume":"30","author":"Sahu","year":"1993","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0230","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titers","volume":"8","author":"Santos","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jim.2013.02.007_bb0240","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/IAI.72.6.3344-3349.2004","article-title":"Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide","volume":"72","author":"Sprong","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.02.007_bb0245","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.173.4.1025","article-title":"The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain","volume":"173","author":"Tao","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2013.02.007_bb0250","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0264-410X(02)00630-8","article-title":"Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era","volume":"21","author":"Trotter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2013.02.007_bb0255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/CVI.00102-07","article-title":"Seroprevalence of bactericidal and anti-outer membrane vesicle antibody to Neisseria meningitidis group B in England","volume":"14","author":"Trotter","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0260","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/CVI.00279-08","article-title":"Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era","volume":"15","author":"Trotter","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/CVI.05515-11","article-title":"Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009","volume":"19","author":"Trotter","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0270","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.4049\/jimmunol.166.10.6250","article-title":"Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B","volume":"166","author":"Vidarsson","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.02.007_bb0275","first-page":"72","article-title":"Requirements for meningococcal polysaccharide vaccine (requirements for biological substances no. 23)","volume":"594","author":"World Health Organisation","year":"1976","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.jim.2013.02.007_bb0280","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect. Immun."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591300063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591300063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T19:24:51Z","timestamp":1688066691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217591300063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":56,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S002217591300063X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2013.02.007","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}